End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5,580 KRW | +1.82% |
|
+9.84% | -18.78% |
06-10 | Bio Plus Co., Ltd announces an Equity Buyback for KRW 5,000 million worth of its shares. | CI |
06-10 | Bio Plus Co., Ltd authorizes a Buyback Plan. | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-18.78% | 232M | |
+2.99% | 95.18B | |
-4.34% | 37.55B | |
-10.41% | 33.75B | |
+75.79% | 28.2B | |
-14.61% | 15.63B | |
-3.46% | 13.63B | |
-12.31% | 11.5B | |
+184.77% | 10.81B | |
-54.13% | 9.23B |
- Stock Market
- Equities
- A099430 Stock
- News Bio Plus Co., Ltd
- Novelgen announced that it expects to receive KRW 2.99985 billion in funding from BioPlus Co., Ltd.